OTCMKTS:VICP Vicapsys Life Sciences (VICP) Stock Price, News & Analysis → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free VICP Stock Alerts $0.44 0.00 (0.00%) (As of 05/10/2024 ET) Add Compare Share Share Today's Range$0.44▼$0.4450-Day Range$0.44▼$2.2552-Week Range$0.44▼$3.00Volume2,500 shsAverage Volume83 shsMarket Capitalization$14.24 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsSEC FilingsStock AnalysisChartEarningsFinancialsSEC Filings Get Vicapsys Life Sciences alerts: Email Address Ad Weiss RatingsThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. About Vicapsys Life Sciences Stock (OTCMKTS:VICP)Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN, a proprietary product. The company's product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics International, Inc. and changed its name to Vicapsys Life Sciences, Inc. in September 2017. Vicapsys Life Sciences, Inc. was incorporated in 1997 and is based in Suwanee, Georgia.Read More VICP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VICP Stock News HeadlinesApril 28, 2024 | usatoday.comBest term life insurance: Expert-rated in April 2024November 4, 2023 | morningstar.comAnavex Life Sciences Corp AVXLMay 12, 2024 | Crypto 101 Media (Ad)Shocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.August 9, 2023 | finance.yahoo.comVICP - Vicapsys Life Sciences, Inc.July 3, 2023 | msn.comViCapsys files for Nasdaq uplisting, $8M public offeringFebruary 19, 2023 | benzinga.comGlobal Life Science Tools Strategic Business Report 2023: Rapid Growth in Biopharma Industry and Rising Investments in R&D to Boost Market ProspectsSeptember 29, 2022 | finance.yahoo.comViCapsys Life Sciences Appoints Three New Board MembersApril 18, 2022 | finance.yahoo.comViCapsys Life Sciences Appoints Federico Pier as Permanent Chief Executive OfficerSee More Headlines Receive VICP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vicapsys Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorConstruction Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:VICP CUSIPN/A CIK1468639 Webvicapsys.com Phone(972) 891-8033FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-990,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-598.80% Debt Debt-to-Equity RatioN/A Current Ratio0.13 Quick Ratio0.13 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.03) per share Price / Book-14.80Miscellaneous Outstanding Shares32,070,000Free Float30,153,000Market Cap$14.24 million OptionableNot Optionable Beta-5.63 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Federico Pier (Age 56)CEO, Executive Chairman & Interim President Comp: $120kMr. Jeffery Wright CPA (Age 41)CPA, Chief Financial Officer Comp: $90kDr. Mark C. Poznansky M.D.Ph.D., Chief Scientist Advisor & FounderKey CompetitorsInnoNASDAQ:INHDWilliams Industrial Services GroupOTCMKTS:WLMSIntelligent Living Application GroupNASDAQ:ILAGENGlobalNASDAQ:ENGTSSOTCMKTS:TSSIView All Competitors VICP Stock Analysis - Frequently Asked Questions How have VICP shares performed in 2024? Vicapsys Life Sciences' stock was trading at $2.74 on January 1st, 2024. Since then, VICP shares have decreased by 83.8% and is now trading at $0.4440. View the best growth stocks for 2024 here. How do I buy shares of Vicapsys Life Sciences? Shares of VICP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:VICP) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsShocking: One AI startup's revenue could surge 4,735%Manward PressElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchYou need to know these two things about AI stocks ASAP…InvestorPlace[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vicapsys Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
